Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

Running Head: COPD Patients Using ED or Hospitalization

Funding Support: None

Date of Acceptance: December 9, 2015

Abbreviations: chronic obstructive pulmonary disease, COPD; emergency department, ED; Behavioral Risk Factor Surveillance System, BRFSS; odds ratio, OR; confidence intervals, CI; Centers for Disease Control and Prevention, CDC; body mass index, BMI; cardiovascular disease, CVD

Citation:Kumbhare SD, Beiko T, Wilcox SR, Strange C. Characteristics of COPD patients using United States emergency care or hospitalization. Chronic Obstr Pulm Dis. 2016; 3(2): 539-548. doi:


Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality throughout the world. It is the third leading cause of death in the United States.1,2 The prevalence of COPD ranges from 8% to 20% worldwide and is the only disease with increasing death rates, rising by 16% since 2002.3 COPD exacerbations impact the natural progression of disease, are responsible for the majority of costs, and are associated with high mortality.4

COPD patients often need emergency department (ED) visits or hospital admissions because of acute exacerbations that may progress to respiratory failure. Over the past decade, studies have defined the major predictors of exacerbation to be past exacerbations.5 However, the majority of exacerbations do not present to the ED or to hospitals. It remains unknown how many of these visits also are associated with deterioration of other conditions.6

Hospitalizations associated with COPD continue to be a significant part of spending of health care resources. In 2010, the health cost associated with COPD in the United States was 50 billion dollars.4 These costs increase as the severity and exacerbation frequency of COPD becomes worse. The spending associated with hospitalization accounts for more than 70% of COPD-related medical care costs.7 Minimizing the number of preventable hospitalizations could lead to cost reduction8,9 and allocation of the resources to preventive care in COPD.

COPD often coexists with other systemic comorbid diseases, such as cardiovascular disease, hypertension, osteoporosis, neuropsychiatric conditions, arthritis, and diabetes mellitus.10 These comorbidities have shared risk factors with COPD, and can be considered to influence one another and affect mortality.11 These comorbidities impact patients' health status and interfere with COPD management.1 However, there is limited population-based epidemiologic data on the COPD patients who use the emergency department or get hospitalized for their disease.

This study was designed to describe the population based on socio-demographic characteristics of the COPD patients with ED visits or hospitalization and to determine their prevalence of common comorbidities.


This study used data collected by the Centers for Disease Control and Prevention (CDC). The Behavioral Risk Factor Surveillance system (BRFSS) survey was conducted in 2012 from 50 states and the District of Columbia and U.S. territories using telephone interviews. Details of the BRFSS and the modules used in the study are found in the online supplement. The core module of the 2012 BRFSS collected information on socio-demographic characteristics (age, sex, race, marital status, height, weight, exercise, disability, and health insurance), and chronic diseases (including myocardial infarction, coronary heart disease/ angina, cancer, stroke, depression, arthritis, kidney disease, and diabetes). Eleven states (Arizona, Connecticut, Illinois, Michigan, Minnesota, Mississippi, Montana, Nevada, Oregon, South Carolina, and Tennessee) elected to collect data on an optional COPD module used for this analysis. We chose to limit the analysis to individuals aged 35 or over to lessen respondents with asthma. Smoking was characterized as a categorical variable for current, past, or never smokers.

A history of COPD was defined as an affirmative response to the following question: “Have you ever been told by your physician that you have chronic obstructive pulmonary disease or COPD, emphysema or chronic bronchitis?” We stratified the characteristics of COPD patients on the basis of the ED visits or hospitalization status over the 1 year prior to the survey from the question: “Have you had to visit an emergency room or be admitted to the hospital in the past 12 months because of your COPD, chronic bronchitis, or emphysema?”

Statistical Analysis

We described the distribution of demographic factors for the patients in the study cohort aged ≥ 35 years based on ED visits or hospitalization status. First, we tested for unadjusted associations between the variables and the status of ED visits or hospitalization using Chi-square test or t-test, as appropriate. The value p<0.1 was utilized for assessing significance for univariate models and determining potential factors to include in multiple logistic regression where p<0.05 was considered significant. A multinomial logistic regression model then examined the association between the ED visits or hospitalization and individual comorbidities adjusting for demographic factors and smoking status. To facilitate interpretation, the results of the analysis were expressed as an odds ratio (OR) and associated 95% confidence interval (95% CI) for estimation of the prevalence of comorbidities. Statistical analysis was performed using SAS 9.4 package for Windows (SAS Institute Inc., Cary, NC, USA).


Of 90,851 respondents from 11 states in the United States, 7755 (8.5%) were diagnosed with COPD and completed the COPD module. We analyzed participants with age ≥ 35 years and those without missing responses (89.4%). Of these, 1131(16.3%) reported an ED visit or hospitalization (Figure 1).


Unexpectedly, the COPD patients who had ED visits or hospitalization were younger (64.6±12.2 years) compared to those without (66.1±11.8 years, p<0.001). This difference was driven by a higher proportion of individuals > age 65 years who did not have an ED visit or hospitalization as depicted in Figure 2.


Although there is a female preponderant response to the BRFSS, there was no significant difference in gender between those with COPD-related ED visits or hospitalization and those without (p=0.49)(Table 1).


In the analysis comparing race, non-Hispanic whites (80.6%) were the largest number of participants in the study despite oversampling efforts to more closely match the U.S. census by BRFSS methodology. The risk of ED visits or hospitalization was highest in non-Hispanic black individuals compared to the non-Hispanic whites [OR 2.00, 95% CI (1.65-2.42)]. We also found high rates of ED visits or hospitalization in Hispanics compared to non-Hispanic whites [OR 1.61, 95% CI (1.06-2.43)].

Comparing education between the 2 groups, the individuals who graduated from high school [OR 0.70, 95% CI (0.58-0.83)], attended technical college [OR 0.72, 95% CI (0.60-0.87)], or graduated from college [OR 0.55, 95% CI (0.44-0.68)] had a lower risk of ED visits or hospitalization compared to those without any of these educational achievements. The ED visit or hospitalization experience for those who were divorced or widowed or separated was higher (55.9%) compared to those who were not (50.5%) (p =0.0008). The patients with COPD who had an ED visit or hospitalization had lower income (p<0.0001) and employment (p<0.0001) compared to those without. Interestingly, there was no significant difference in ED visits or hospitalization status by smoking category (p=0.1091) (Table 1).

Health insurance was present for 91.7% and 92.0% of the cohorts and included prepaid plans such as health maintenance organizations and government plans such as Medicare, Medicaid, or the Indian Health Service. Although the health care coverage was similar, a higher proportion of individuals with ED visits or hospitalization (23.4%) reported that they could not visit a doctor because of financial difficulties compared to those without (16.7%) (p<0.0001). The ED visits or hospitalization rate was higher in western (16.8%) and southern regions (16.6%) of the United States when compared to the northeast region (14.9%) (Figure 2). Further evaluation of disability status revealed that the individuals with ED visits or hospitalization had more disability when compared to those without hospitalization or ED visits (79.0% versus 60.9%, p<0.0001).

Table 2 shows the odds ratio for ED visits or hospitalizations was higher if the COPD patient also had one of the listed common comorbidities.


Arthritis was the most frequent comorbidity, present among those who visited an ED or had a hospitalization (71.5% versus 64.1% for those without an ED visit or hospitalization, p <0.0001). Kidney disease was the least frequent comorbidity in COPD (12.1% versus 8.3%, p<0.0001). Other common comorbidities reported in the BRFSS included coronary heart disease/angina (30.7% versus 19.8%, p<0.0001), stroke (16.7% versus 11.2%, p<0.0001), cancer (22.0% versus 17.9%, p=0.0001), depression (46.7% versus 35.8%, p<0.0001), and diabetes (29.7% versus 23.6%, p=0.0122). Figure 3 illustrates that the risk of comorbidities is higher in those who had ED visits or hospitalizations.


Differences in the ED visits or hospitalization cohort were also found in low and high body mass index (BMI) categories (Figure 4).



Hospital utilization generates the majority of COPD-related health care expenses.12Identifying patients who use the ED or hospital is clinically important, since mortality increases with the frequency of exacerbations.13 Because most current data about COPD emergency care is derived from single hospital system databases, this population-based study provides a more comprehensive picture of the socio-demographic factors and comorbidities of these COPD patients across the United States.

Most striking were the demographic differences between the emergency care and non-emergency care populations. Although older age is considered a risk factor for hospitalization,14 our study found that the patients presenting for ED visits or hospitalization were younger. The large power associated with the BRFSS dataset allowed small differences in age to be statistically significant; however, the fact that young individuals make up a significant percentage of this COPD cohort has been shown in other studies.15-17 Although older individuals may have a higher risk of admission to the hospital, we speculate that younger individuals are more likely to visit an emergency department for less severe exacerbations of symptoms. Unfortunately, the BRFSS does not contain data that could clarify linkages between ED use and hospital admissions.

Gender was not associated with a higher risk for ED visits or hospitalization as has been seen in previous studies17,18 Although some studies have found that female sex is a protective factor for ED visits or hospitalization,15 other studies have found higher ED visits or hospitalization rates.19As the difference in tobacco use between sexes continues to narrow20 and we recognize that women share the burden of smoking-related disease with men; this finding is not unexpected.

Surprisingly, no differences in tobacco use were found between the cohorts. Tobacco smoking is considered to be one of the most important factors associated with COPD-related hospitalizations, worse outcomes, and comorbid conditions such as cardiovascular disease. As current smoking trends have reduced since 1965,1 other risk factors such as exposure to air pollution, secondhand smoke, occupational dust, chemicals and hereditary conditions may play an increasingly significant role.21 Tobacco cessation counseling should be addressed during each encounter with the patient. However, the data suggests that issues related to health care access should transition to a top priority.

Socioeconomic status starting early in life plays an important role affecting the risk of developing COPD independent of smoking and gender.22 As has been seen in other studies, education, income, and employment were inversely associated with ED visits or hospitalization.19 Being married was found more often in the cohort without ED visits or hospitalization.5,23,24 The relationship of socio-economic status with ED visits or hospitalization is likely complex. Although more smoking, more occupational exposure to dust and fumes, and more secondhand smoke may influence disease pathogenesis,25,26 less contact with health care, more obesity, and less exercise are demographics that are amenable to interventions.27 Since we speculate that many of these disparities were associated with ED presentations, alternative interventions to provide social support, improve home environmental triggers of exacerbations, and improve alternative models of health care delivery and medications should be studied.

Interestingly, we found that many of the patients with COPD were not inclined to visit a physician despite having health insurance. Although 91.7% were covered by health insurance, 23.7% could not see a doctor because of the financial difficulties. The impact of high insurance deductibles, residual medical debt,28 or medication costs on COPD care remain understudied barriers to care. Since regular COPD medication use prevents exacerbations, this finding requires a reassessment of health care delivery in COPD populations.

Low physical activity was found to be an independent risk factor for ED visits or hospitalization.29 Our finding is consistent with other studies. Since pulmonary rehabilitation within 1 month of hospital discharge is associated with less re-hospitalization,30 there is uncertainty whether the benefits with exercise occur in domains of physiology (improved muscle mitochondrial oxidative capacity and less CO2 production), improved medication compliance, improved mucus clearance, or other factors.31

In our study, extremes of BMI are associated with higher ED visits or hospitalization. Low BMI was associated with emergency care needs, consistent with other studies.15,18,32,33 In other studies, a high BMI has been associated with increased risk of death, in part associated with the higher prevalence of comorbidities.34 This suggests that comorbidities play an important role in the outcome of COPD. Data on the morbidly obese COPD patient is very scarce. Our study suggests that these patients are at the highest risk of ED visits or hospitalization. An observational study from the National Health and Nutritional Examination Survey III reported that these individuals die of unknown respiratory causes.35 As morbidly obesity increases in prevalence, these individuals with COPD should be studied carefully to better understand this observation.

The group of COPD patients with ED visits or hospitalization had higher proportions of patients with comorbidities compared to those without. Similar to other studies,36 cardiovascular disease (CVD) was a frequent comorbidity. In a retrospective cohort study, it was found that patients with comorbid COPD and CVD had twice the risk of a COPD-related hospitalization compared to patients without comorbid CVD.37 This study shows similar findings and may impact unplanned readmissions.38 However, the breadth of comorbidity differences between the 2 cohorts is also impressive for disease states that range from cancer to depression.39 This study cannot define the cause of ED visits or hospitalization. However, a focus on comprehensive care of the chronically-ill COPD patient who presents to emergency care likely will be needed to make an impact on health.

There were some limitations to this study including those associated with the BRFSS survey methodology.2,40 First, information on symptom severity and pulmonary function testing were not available. Even though we did not have lung function tests, the BRFSS inquires whether lung function testing has been performed. We analyzed the data using only those individuals who had lung function tests finding few differences (data not shown). Second, due to its cross-sectional design, the study shows associations but does not identify causal relationships. The finding that these patients are younger raises the question of whether asthma or an asthma COPD overlap syndrome was present. Table 2 shows that some individuals who were diagnosed with COPD by a physician and eligible for this study, also answered that they had asthma. Third, data regarding the reason for the hospital visit is not available, although the question implies a respiratory cause. However, this deficiency is minor compared to the ability of the BRFSS to provide a population-based snapshot of the emergency care-seeking COPD patient.


In conclusion, the COPD modules of the BRFSS have provided a unique opportunity to characterize the COPD populations using emergency care in the United States. Our study exemplifies current efforts to analyze and report population-based, COPD-related public health data, a major goal of the CDC.41 COPD patients with lower socio-economic status, extremes of BMI, more disabilities, and frequent comorbidities were independently associated with COPD ED visits or hospitalization. The study also suggests that opportunities to improve health care access, increase pulmonary rehabilitation utilization, and address COPD comorbidities will be needed to better manage COPD patients using emergency services.

Declaration of Interest

Drs. Suchit Kumbhare, Tatsiana Beiko, and Susan R. Wilcox do not have conflicts of interest. Dr. Charlie Strange has current, past, or pending grants in COPD from the Alpha-1 Foundation, Baxter, CSL Behring, Entera Health, Grifols, and the National Institutes of Health. He consults for AstraZeneca, Boehringer-Ingelheim, CSL Behring, Grifols, PlasmaTech, PneumRx, Pulmonx, and Uptake Medical on COPD.

Online Supplement

BRFSS Methods

The 2012 Behavioral Risk Factor Surveillance System (BRFSS) survey uses telephone interviews and relies on self-reported characteristics rather than clinical measurements. It is the single largest annual health survey conducted in the US each year. The large survey population is more representative of the heterogeneous types of patients that would enter a physician’s office than subjects commonly selected for clinical studies. The respondents in households with either landline or cellular telephones were selected using a complex stratified sampling method and new weighting procedures that have been adopted since 2011 in order to better reflect the nation’s health status. Details of sampling methodology is found at ( The BRFSS in 2012 included questions about socio-demographic characteristics, risk behaviors, chronic diseases, disability, self-reported height, and self-reported weight. The respondents who reported COPD and those who completed the COPD module in the 2012 BRFSS were included in the study. The COPD module was chosen for inclusion by 11 states: Arizona, Connecticut, Illinois, Michigan, Minnesota, Mississippi, Montana, Nevada, Oregon, South Carolina, and Tennessee.

Respiratory Outcomes

A self-reported history of COPD was defined as an affirmative response to the question “Has a doctor, nurse, or other health professional ever told you that you have chronic obstructive pulmonary disease or COPD, emphysema or chronic bronchitis?” Current asthma was defined for persons who answered in the affirmative to the following two questions: “Has a doctor, nurse, or other health professional ever told you that you have asthma?” and “Do you still have asthma?” Persons who reported ‘don’t know/not sure’ as a response to either COPD or asthma questions were defined as not having been diagnosed with that condition. Persons who reported ‘Yes’ as a response to both COPD and both asthma questions were labeled as diagnosed with the Asthma-COPD overlap syndrome (ACOS). The respondent completed the COPD module if there was a positive response to the question “Has a doctor, nurse, or other health professional ever told you that you have chronic obstructive pulmonary disease or COPD, emphysema or chronic bronchitis?”. There were three questions in the COPD module covering quality of life, emergency room (ER) visits/ hospitalization in the last 12 months, and number of daily COPD medications used. The first question assessing quality of life was defined based on response to the question: “Would you say that shortness of breath affects the quality of your life?” Hospitalization/ ER visit use was assessed as a single variable using the question:” Did you have to visit an emergency room or be admitted to the hospital in the past 12 months because of your COPD, chronic bronchitis, or emphysema?”

Chronic Health Conditions

All respondents were asked “Has a doctor, nurse, or other health professional ever told you that you had any of the following?” to a series of chronic health conditions: myocardial infarction, coronary heart disease, stroke, cancer, arthritis, depression, kidney disease, and diabetes. For each, response options included yes, no or not sure. A yes response was calculated as a co-morbidity. Persons who reported yes to any chronic health condition mentioned above were labeled as diagnosed with at least one comorbidity.

Socio-demographic Factors

For these analyses, socio-demographic characteristics included age, sex, and race/ethnicity (non-Hispanic white, non-Hispanic black, other race, multiracial non-Hispanic, Hispanic). Respondents were asked the highest grade or year of school completed and responses were grouped into did not graduate high school (grades 1 through 8, or grades 9 through 11), high school graduate or equivalent (grade 12 or general education development certificate (GED)), attended technical college or at least some college (1 to 3 years college, some college or technical school) and graduated from college (college >4 years, or college graduate). Marital status was grouped into 3 categories: married, never married/ member of unmarried couple and divorced/ widowed/ separated. Income was assessed from the question: “Is your annual household income from all the sources—“ with responses less than $15000, more than $15000 but less than $25000, more than $25000 but less than $35000, more than $35000 but less than $50000, and more than $50000. Employment status was grouped in three categories employed, homemaker/student, and unemployed. Body mass index was assessed using questions where all respondents were asked “about how much do you weigh without shoes” with responses in pounds, which were later converted to kilograms. “About how tall are you without shoes?” was reported in feet and inches, which was later converted to meters. Body mass index (BMI) was then calculated as kilograms/meter2 and grouped into the following five categories: underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), obese (30.0-39.9 kg/m2), and morbidly obese (≥40.0 kg/m2).

Health Behaviors and Disability

For these analyses, smoking status were defined by three categories never smoker, former smokers, and current smokers from the responses to the question “Have you smoked at least 100 cigarettes in your entire life?” Former smokers were defined by a "yes" response to the question mentioned above and a response of “not at all” to a second question, “Do you now smoke cigarettes, every day, some days, or not at all?” Current smokers were defined by an affirmative response to the first question and a response of “every day” or “some days” to the second.

Disability was defined by an affirmative response to the following question – “Are you limited in any way in any activities because of physical, mental, or emotionalproblems?”

1. Global initiative for chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD (update 2015). GOLD website. Published 2015. Accessed November 29, 2015.

2. Powell-Griner E, Centers for Disease Control and Prevention. Uses and limitations of the behavioral risk factor surveillance system data. American Statistical Association website. Published 1998. Accessed November 29, 2015.

3. Menezes AMB, Perez-Padilla R, Jardim JRB, et al, Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366(9500): 1875-1881. doi:

4. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecom Outcomes Res. 2013; 5: 235-245.

5. Yeatts KB, Lippmann SJ, Waller AE, et al. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest. 2013; 144(3): 784-793. doi:

6. Donaldson GC, Wedzicha JA. COPD exacerbations -1: Epidemiology. Thorax.2006; 61(2): 164-168. doi:

7. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000. 117(2 Suppl): 5S-9S. doi:

8. Shi L, Samuels ME, Pease M, Bailey WP, Corley EH. Patient characteristics associated with hospitalizations for ambulatory care sensitive conditions in South Carolina. South Med J. 1999; 92(10): 989-998. doi:

9. O'Neil SS, Lake T, Merrell A, Wilson A, Mann DA, Bartnyska LM. Racial disparities in hospitalizations for ambulatory care-sensitive conditions. Am J Prev Med. 2010; 38(4): 381-388. doi:

10. Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013. 22(130): 454-475. doi:

11. Donaldson G, Seemungul TAR, Bhowmik A, Wedzicha JA, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002. 57(10): 847-852. doi:

12. Kashihara D Carper K, Medical Expenditure Panel Survey. National health care expenses in the U.S. civilian noninstitutionalized population, 2009-Statistical Brief #355. Agency for Healthcare Research and Quality website. Published January 2012. Accessed November 2015.

13. Soler-Catalu-a JJ, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60(11): 925-931. doi:

14. Gadoury, MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J. 2005; 26(5): 853-857. doi:

15. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159(1):158-164. doi:

16. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jefferies DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5): 1418-1422. doi:

17. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997; 52(1):67-71. doi:

18. Garcia-Aymerich J, Monsό E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation-- EFRAM study. Am J Respir Crit Care Med. 2001; 164(6): 1002-1007. doi:

19. Trachtenberg AJ, Dik N, Chateaur D, Katz A. Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a Canadian city. Annals Fam Med. 2014; 12(5): 402-407. doi:

20. Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2015;64(44):1233–1240. Centers for Disease Control website. Published November 13, 2015. Accessed December 8, 2015.

21. Eriksson S. Pulmonary emphysema and alpha-1 antitrypsin deficiency. Acta Med Scand. 1964. 175:197-205. doi:

22. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J. 1999;13(5): 1109-1114. doi:

23. Hasegawa K, Tsugawa Y, Tsai C-L, Brown DFM, Carmargo Jr CA. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respir Res. 2014. 15(1): 40-40. doi:

24. Tsai C-L, Griswold SK, Clark S, Carmargo Jr CA. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med.2007; 22(6): 799-804.doi:

25. Pauwels RA, Buist S, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001. 163(5):1256-1276. doi:

26. Lange P, Marott JL, Vestbo J, Sylvan I, Nordestgaard BG. Socioeconomic status and prognosis of COPD in Denmark. COPD. 2014; 11(4): 431-437. doi:

27. Steenland, K, Henley J, Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959–1996. Am J Epidemiol. 2002; 156(1):11-21. doi:

28. New survey findings: 79 million U.S. adults have medical bill problems or are paying off medical debt; low and moderate income families hit hardest [news release]. New York, NY: The Commonwealth Fund; August 20, 2008. Accessed November 2015.

29. Bahadori K, FitzGerald JM. Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review. Int J Chron Obstruct Pulmon Dis. 2007. 2(3): 241-251.

30. Seymour JM, Moore L, Jolley CJ, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax.2010; 65(5):423-428. doi:

31. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society Statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):1011-1027.

32. Hallin R, Gudmundsson G, Ulrik CS, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007. 101(9):1954-1960. doi:

33. Liu Y, et al. Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease. Respir Med. 109(7): p. 851-859. doi:

34. Divo MJ, Cabrera C, Casanova C, et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis (Miami).2014;1(2): 229-238. doi:

35. Jordan Jr JG, Mann JR. Obesity and mortality in persons with obstructive lung disease using data from the NHANES. South Med J. 2010;103(4):323-330.

36. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010; 65(11): 956-962. doi:

37. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011. 105(10): 1516-1522. doi:

38. Yu T-C, Zhou H, Suh K, Arcona S. Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. Clinicoecon Outcomes Res. 2015; 7:37-51. doi:

39. Hanania NA, Mȕllerova H, Locantore NW, et al. Determinants of depression in the eclipse chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604-611. doi:

40. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System: Comparability of Data BRFSS 2012. CDC website. . Published July 15, 2013. Accessed November 29, 2015.

41. Centers for Disease Control and Prevention. Public Health Strategic Framework for COPD Prevention. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Accessed November 29, 2015.


  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
  • Characteristics of COPD Patients Using United States Emergency Care or Hospitalization

Share This Article

E-mail this article to a friend